Please login to the form below

Not currently logged in
Email:
Password:

DARPin

This page shows the latest DARPin news and features for those working in and with pharma, biotech and healthcare.

Allergan will start phase III DARPin trials next year

Allergan will start phase III DARPin trials next year

Allergan will start phase III DARPin trials next year. Will investigate drug in wet age-related macular degeneration. ... Allergan confirmed yesterday it will start pivotal trials of its DARPin treatment for wet age-related macular degeneration (AMD) in

Latest news

More from news
Approximately 2 fully matching, plus 6 partially matching documents found.

Latest Intelligence

  • Deal Watch January 2018

    Collaboration, licence. 830. Molecular Partners/ Allergan. Option exercise for 2 DARPins from Allergan's ophthalmology alliance signed in 2012.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Real Science Communications

Real Science Communications is a scientific centre of excellence, infusing credibility and scientific rigour into the conversations around health and...

Latest intelligence

image 1
Redefining communications excellence
How to be heard in today’s multichannel, multistakeholder, multimedia world...
AZ Campus
AstraZeneca: building a new ‘open innovation’ pharma company
The construction of its new HQ has suffered some serious delays, but new R&D and commercial success are lifting AstraZeneca’s prospects...
Erik Nordkamp
In conversation with Pfizer’s Erik Nordkamp
Pfizer’s UK general manager talks to PME about the NHS at 70, the potential of pharma partnerships and some lessons from Europe...

Infographics